DRRX - DURECT CORP
IEX Last Trade
0.99
0 0%
Share volume: 970
Last Updated: Fri 27 Dec 2024 08:29:52 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.99
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-03 | 2023-03-08 | 2023-05-09 | 2023-08-10 | 2023-11-14 | 2024-03-28 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 69.979 M | 68.472 M | 60.100 M | 58.349 M | 48.657 M | 54.728 M | 45.189 M | 36.221 M | |
| Current Assets | 60.455 M | 59.346 M | 51.394 M | 50.504 M | 40.290 M | 43.780 M | 34.671 M | 26.085 M | |
| Inventories | 2.133 M | 2.269 M | 2.113 M | 2.211 M | 2.262 M | 2.521 M | 2.219 M | 2.398 M | |
| Other Current Assets | 3.006 M | 1.955 M | 2.375 M | 2.522 M | 1.829 M | 1.391 M | 1.511 M | 1.228 M | |
| Short Term Investments | 3.006 M | 1.955 M | 2.375 M | 2.522 M | 1.829 M | 1.391 M | 1.511 M | 1.228 M | |
| Total Receivables | 1.204 M | 3.229 M | 3.423 M | 1.401 M | 1.304 M | 883.000 K | 1.261 M | 1.020 M | |
| Current Cash | 54.112 M | 51.893 M | 43.483 M | 44.220 M | 34.745 M | 38.985 M | 29.680 M | 21.439 M | |
| Total Non-current Assets | 9.524 M | 9.126 M | 8.706 M | 7.845 M | 8.367 M | 10.948 M | 10.518 M | 10.136 M | |
| Property Plant Equipment | 222.000 K | 211.000 K | 188.000 K | 144.000 K | 149.000 K | 127.000 K | 91.000 K | 58.000 K | |
| Other Assets | 261.000 K | 256.000 K | 256.000 K | 0.000 | 6.000 K | 128.000 K | 128.000 K | 128.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 6.169 M | 6.169 M | 6.169 M | 6.169 M | 6.169 M | 6.169 M | 6.169 M | 6.169 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 69.979 M | 68.472 M | 60.100 M | 58.349 M | 48.657 M | 54.728 M | 45.189 M | 36.221 M | |
| Total liabilities | 33.275 M | 33.618 M | 35.115 M | 43.007 M | 43.157 M | 40.322 M | 30.406 M | 27.921 M | |
| Total current liabilities | 10.593 M | 13.357 M | 34.004 M | 42.086 M | 41.430 M | 36.752 M | 27.011 M | 24.739 M | |
| Accounts Payable | 3.230 M | 2.139 M | 3.106 M | 2.006 M | 980.000 K | 1.314 M | 1.777 M | 782.000 K | |
| Other liabilities | 1.694 M | 1.694 M | 851.000 K | 921.000 K | 924.000 K | 643.000 K | 693.000 K | 716.000 K | |
| Current long term debt | 950.000 K | 3.106 M | 21.170 M | 21.303 M | 20.721 M | 18.700 M | 16.663 M | 14.612 M | |
| Long term debt | 19.949 M | 17.928 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.694 M | 1.694 M | 851.000 K | 921.000 K | 924.000 K | 643.000 K | 693.000 K | 716.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 36.704 M | 34.854 M | 24.985 M | 15.342 M | 5.500 M | 14.406 M | 14.783 M | 8.300 M | |
| Common stock | 227.742 M | 227.774 M | 22.788 M | 23.767 M | 24.508 M | 27.211 M | 29.538 M | 30.637 M | |
| Retained earnings | -548.442 M | -550.913 M | -561.382 M | -573.369 M | -584.550 M | -587.565 M | -589.006 M | -596.649 M |